1 Introduction Metabolic dysfunctionassociated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease (NAFLD)) is a dynamic chronic non-communicable liver disease, which displays hepatic steatosis with one or more cardiometabolic risk factors in the absence of other causes of hepatic steatosis, such as drug-induced or alcohol-related steatosis (Sarkar and Kushner, 2025)
National drug shortages have significantly impacted access to brand-name semaglutide products
Participants in the study were administered semaglutide at a starting dose of 0.25 mg, eventually increasing it over 16 weeks, along with a reduced-calorie diet and physical activity
Maintenance: After youve reached your target weight, well help you shift into a maintenance phase that promotes long-term stability
Fifteen of those lost pounds were not from my GLP-1, exercise, or dietary changes but from something else entirely: skin-removal surgery